| GWAS |
- Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy) ( 31835028
)
- Brain morphology (min-P) ( 32665545
)
- Brain morphology (MOSTest) ( 32665545
)
- Cataracts ( 34127677
)
- Cortical surface area (MOSTest) ( 32665545
)
- Diastolic blood pressure ( 30224653
)
- Estimated glomerular filtration rate ( 31152163
)
- Red cell distribution width ( 32888494
)
- Refractive error ( 32231278
)
- Schizophrenia ( 25056061
28991256
29483656
)
- Subcortical volume (min-P) ( 32665545
)
- Subcortical volume (MOSTest) ( 32665545
)
- Type 2 diabetes ( 30054458
)
|
- Adverse response to lamotrigine and phenytoin ( 22379998
)
- Attention function in attention deficit hyperactive disorder ( 26174813
)
- Bone mineral density change response to combined chemotherapy in acute lymphoblastic leukemia ( 29266176
)
- Cannabis use (initiation) ( 22823124
)
- Cellular nuclear factor (erythroid-derived 2)-like 2 levels ( 30767168
)
- Chronic periodontitis (mean interproximal clinical attachment level) ( 27601451
)
- Crohn's disease ( 17684544
)
- Femur bone mineral density x serum urate levels interaction ( 34046847
)
- Fibrinogen levels (smoking status, alcohol consumption or body mass index interaction) ( 25551457
)
- Hepcidin levels ( 27846281
)
- Hepcidin/transferrin saturation ratio ( 27846281
)
- Hippocampal sclerosis ( 25188341
)
- Methadone dose in opioid dependence ( 28115739
)
- Obesity-related traits ( 23251661
)
- Prudent dietary pattern ( 28644415
)
- Response to amphetamines ( 22952603
)
- Response to long-chain n-3 polyunsaturated fatty acid supplementation (change in triglyceride levels) ( 24847101
)
- Triglyceride levels in HIV infection ( 33109212
)
- Weight ( 28552196
)
|
